VICINI CHILOVI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 1.857
EU - Europa 637
AS - Asia 364
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.869
Nazione #
US - Stati Uniti d'America 1.855
UA - Ucraina 264
CN - Cina 251
PL - Polonia 98
DE - Germania 82
FI - Finlandia 58
HK - Hong Kong 52
IT - Italia 35
IE - Irlanda 33
GB - Regno Unito 32
SG - Singapore 32
FR - Francia 24
IN - India 11
IR - Iran 5
JP - Giappone 4
SE - Svezia 4
TR - Turchia 4
VN - Vietnam 4
BE - Belgio 3
AU - Australia 2
EU - Europa 2
MU - Mauritius 2
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
IS - Islanda 1
UY - Uruguay 1
Totale 2.869
Città #
Fairfield 303
Woodbridge 250
Jacksonville 163
Houston 162
Ashburn 138
Cambridge 118
Wilmington 115
Seattle 111
Warsaw 98
Ann Arbor 91
Chandler 90
Princeton 63
Beijing 57
Nanjing 56
Hong Kong 52
New York 47
Dublin 33
Helsinki 25
Nanchang 20
Hebei 18
Singapore 18
Changsha 13
Des Moines 13
San Diego 13
Shenyang 13
Tianjin 11
Shanghai 10
Jinan 8
Milan 8
San Mateo 8
Auburn Hills 6
Hangzhou 6
San Francisco 6
Kunming 5
Verona 5
Zhengzhou 5
Ardabil 4
Dong Ket 4
Haikou 4
Jiaxing 4
Lanzhou 4
Leawood 4
Monmouth Junction 4
Boardman 3
Brescia 3
Brussels 3
Como 3
Ningbo 3
Norwalk 3
Redwood City 3
Taiyuan 3
Augusta 2
Cremona 2
Guangzhou 2
Indiana 2
Kocaeli 2
Lodi 2
Los Angeles 2
Shaoxing 2
Taizhou 2
Takamatsu 2
Albuquerque 1
Bangalore 1
Cairo 1
Camisano Vicentino 1
Canberra 1
Casarano 1
Chiswick 1
Dhaka 1
Edinburgh 1
Fuzhou 1
Kilburn 1
London 1
Melbourne 1
Munich 1
New Bedfont 1
Phoenix 1
Quito 1
Reykjavik 1
Salto 1
Santa Maria Capua Vetere 1
Santo Domingo Este 1
Sofia 1
São Paulo 1
Tokyo 1
Toronto 1
Walnut Creek 1
Wandsworth 1
Yellow Springs 1
Totale 2.258
Nome #
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 202
A case report: doctor, my daughter has Alzheimer's disease. 118
Predictors of progression from mild cognitive impairment to Alzheimer disease. 117
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 108
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 104
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 102
Do vascular risk factors play a role in the progression of mild cognitive impairment? 102
Depressive disorders in dementia. 101
Anxiety symptoms in mild cognitive impairment. 100
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 100
Does reversible MCI exist? 100
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 99
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 98
Does age at observation time affect the clinical presentation of mild cognitive impairment? 96
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 92
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 92
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 91
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 90
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 89
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 88
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 86
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 81
Parkinsonian signs in subjects with mild cognitive impairment 79
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 76
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 71
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 65
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 60
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 60
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 53
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 52
Clinical correlates of executive dysfunctions in mild cognitive impairment 50
Moderate olfactory deficits predict development of dementia within two years in mild cognitive impairment subjects 36
Peripheral oedema related to quetiapine therapy : a case report. 35
I disturbi comportamentali nella Malattia di Alzheimer: aspetti clinici ed epidemiologici. 1
Totale 2.894
Categoria #
all - tutte 13.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020725 0 0 0 131 59 91 86 96 62 96 56 48
2020/2021538 12 54 18 60 20 66 26 77 61 50 75 19
2021/2022235 10 60 5 9 3 12 16 11 13 22 14 60
2022/2023252 31 4 6 14 25 73 4 28 43 0 7 17
2023/2024213 16 6 21 12 4 49 9 8 54 0 4 30
2024/202511 0 7 2 2 0 0 0 0 0 0 0 0
Totale 2.894